BioWorld Asia

May 25, 2011

View Archived Issues

Membrane Receptors Will Open Door to Drug Discovery

EMA Follows FDA Line on Huntexil Development Path

Oxford Biomedica's Parkinson's Drug Improves Motor Function

Spinnovator Raises $56M for New German Start-ups

Going Global: Takeda Paying $13.7B Cash for Nycomed

Shire Acquires Advanced BioHealing for $750M

Other News To Note

GenKyoTex's $20.4M Series C Funds NOX Inhibitor Progress

LONDON – GenKyoTex SA raised CHF18 million (US$20.4 million) in a Series C round, enabling it to take the lead product to the point where it is ready to deliver proof of concept for the company's NOX enzyme inhibition technology. (BioWorld International) Read More

Evotec Shares Fall with Terminated Roche Alliance

Today's news in brief

BioWorld

BioWorld briefs for June 18, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 16, 2026

GLP-1s need technologies for long-term use

BioWorld

For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...

UTRN gene involved in arthrogryposis, study finds

BioWorld Science

Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...

mRNA vaccines are composed of messenger RNA encapsulated in lipid nanoparticles

mRNA flu vaccine can activate broad germinal center response

BioWorld

On the eve of the June 17 Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting, which will discuss Moderna Inc.’s mRNA-1010, researchers...